245 related articles for article (PubMed ID: 7802470)
1. [Prognostic significance of epidermoid metaplasia in urothelial carcinoma of the bladder].
Vecchioli Scaldazza C; Morosetti D
Arch Esp Urol; 1994 Sep; 47(7):671-3. PubMed ID: 7802470
[TBL] [Abstract][Full Text] [Related]
2. [Squamous metaplasia as a prognostic factor in urothelial carcinoma of the bladder].
Vecchioli Scaldazza C; Morosetti C
Minerva Urol Nefrol; 1992; 44(2):97-100. PubMed ID: 1411869
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of pure epidermoid carcinoma of the bladder and transitional cell carcinoma with squamous or mixed differentiated foci].
Budía Alba A; Queipo Zaragozá JA; Pérez Ebrí ML; Fuster Escrivá A; Vera Donoso DC; Vera Sempere FJ; Jiménez Cruz JF
Actas Urol Esp; 1999 Feb; 23(2):111-8. PubMed ID: 10327674
[TBL] [Abstract][Full Text] [Related]
5. Nested variant of transitional cell carcinoma with osseous metaplasia of the urinary bladder: a case report and review of published reports.
Neşe N; Kandiloğlu AR; Atesçi YZ
Int J Urol; 2007 Apr; 14(4):365-7. PubMed ID: 17470174
[TBL] [Abstract][Full Text] [Related]
6. [Bladder carcinoma with sarcomatous changes].
Kamiya M; Tada T; Wakabayashi T; Kishimoto H; Ikei K; Jinno H
Gan No Rinsho; 1986 Mar; 32(3):332-7. PubMed ID: 3712771
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
8. Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder.
Kunze E
Exp Toxicol Pathol; 1998 Sep; 50(4-6):341-55. PubMed ID: 9784006
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
11. [Detection of squamous cell differentiation in experimental tumors of urothelium by using epidermal G2 chalone].
Anichkov NM; Vlasov NN; Okulov VB
Arkh Patol; 1981; 43(4):82-4. PubMed ID: 6453574
[TBL] [Abstract][Full Text] [Related]
12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic aspects of the morphological signs of bladder cancer].
Ermilova VD; Mustia AI; Figurin KM
Arkh Patol; 1994; 56(5):65-9. PubMed ID: 7695498
[TBL] [Abstract][Full Text] [Related]
14. Micropapillary transitional cell carcinoma of the urinary bladder: report of two cases.
Dhouib RS; Abbes I; Mrad K; Sassi S; Leila A; Driss M; Salah R; Romdhane KB
Pathologica; 2005 Oct; 97(5):338-40. PubMed ID: 16480033
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
[TBL] [Abstract][Full Text] [Related]
16. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
17. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
18. [Multiple analysis of morphologic factors with prognostic value in transitional cell papillary carcinoma of the bladder. Retrospective study of 571 cases].
Ramos Soler D; Ferrer Lozano J; Navarro Fos S; Llombart-Bosch A
Actas Urol Esp; 1999 Feb; 23(2):119-26. PubMed ID: 10327675
[TBL] [Abstract][Full Text] [Related]
19. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
[TBL] [Abstract][Full Text] [Related]
20. Prostatic transitional cell carcinoma: pathologic features and clinical management.
Shen SS; Lerner SP
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
